Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

5
Metal markets preparing for a new world disorder

2018-07-09 thestar.com.my
NEW YORK: Donald Trump’s attempts to re-balance global trade have already sent the metals world into a tizzy.
C.WSA C C.PRL C.PRJ C.PRK AA.PRB C.PRG 0486 NUE C.PRC C.WS.B AAI C.PRPCL CGBBW C.WS.A AA.PR C.PRP C.PRU AA C.PRS

149
Oil Trader Trafigura Rebuilds Reputation While Making Billions - Bloomberg

2018-05-31 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
C.WSA XOM BNPQY BP RDSB RDSA C.WS.B C.WS.A C.PRP C.PRU RYDAF C.PRS RDS.B RDS.A C C.PRL C.PRJ C.PRK BNPQF C.PRG 0486 BP.A BP.B C.PRC BNPZY BP C.PRPCL CGBBW RYDBF BPAQF

22
Top ETF Stories of April

2018-05-01 zacks
The first month of April was decent for Wall Street despite a slew of hindrances like the continuation of trade war tensions between China and the United States as well as the tech crash. Overall, top three ETFs, (SPY - Free Report) , DIA and (QQQ - Free Report) added about 2.7%, 2.3% and 3.5%, respectively, in the last one month (as of Apr 30, 2018).
FXE BNO USO FXY RTH XES TWX 0486 TWC

94
RPT-INSIGHT-Inside Deripaska's scramble to soften Russia sanctions blow

2018-04-24 reuters
MOSCOW/LONDON, April 23 (Reuters) - In December, as news reports emerged about potential new U.S. sanctions against Russia, aluminium magnate Oleg Deripaska instructed advisers to draw up contingency plans, according to people close to the businessman and his firms.
GEC GE C.WSA C C.PRL C.PRJ RUALF C.PRK C.PRG 0486 C.PRC C.WS.B C.PRPCL CGBBW C.WS.A C.PRP GNE C.PRU C.PRS

17
Press Metal falls 6.5% as investors take profit

2018-04-24 thestar.com.my
KUALA LUMPUR: Press Metal Aluminium Holdings Bhd saw some profit-taking activities, sliding some 6.5% in early trade.
RTPPF RIO RIO 8869 RIO RTNTF 0486

0
Norway ETF (NORW) Hits New 52-Week High

2018-04-20 zacks
For investors seeking momentum, Global X MSCI Norway ETF (NORW - Free Report) is probably on radar now. The fund just hit a 52-week high and is up nearly 34.6% from its 52-week low price of $10.87/share.
0486

0
China stockpiles alumina for export as supply crunch drives record prices

2018-04-19 thestar.com.my
The Rusal sanctions have upended the aluminium supply chain, as companies cut contracts to use Rusal metal.
0486

0
China stockpiles alumina for export as supply crunch drives record prices

2018-04-19 reuters
MELBOURNE (Reuters) - Chinese traders are preparing to export alumina to reap the profits from record prices for spot cargoes after the United States imposed sanctions on Russia’s United Company Rusal, among the biggest producers of the aluminum raw material.
RUALF 0486

0
Russia sanctions throw global aluminum supply chain into chaos

2018-04-17 bworldonline
The U.S. sanctions on United Co. Rusal that have sent aluminum prices surging should be great news for rival producers like Rio Tinto Group.
532234 NHYKF NHYDY NHY 0486 NATIONALUM

0
Russia Sanctions Throw Global Aluminum Industry Into Chaos - Bloomberg

2018-04-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
532234 NHYKF NHYDY NHY 0486 NATIONALUM

0
Russia Assets Rally on Report Trump Won't Rush Out New Sanctions - Bloomberg

2018-04-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
0486

0
Russian stocks slip as traders brace for another round of U.S. sanctions - MarketWatch

2018-04-16 marketwatch
Russia’s stocks lost ground Monday as the Trump administration looked set to impose more sanctions on that country.
0486

16
RPT-COLUMN-U.S. sanctions are an aluminium-tipped precision strike: Andy Home

2018-04-16 reuters
(Repeats April 13 item. The opinions expressed here are those of the author, a columnist for Reuters)
RTPPF RIO RIO RIO RUALF RTNTF 0486

0
Can You Invest In Russia? (Video)

2018-04-11 seekingalpha
By looking at what happened in 1998, 2009, and 2015 we can assess the magnitude of what can happen.
0486

31
Why These Aluminum ETFs & Stocks Jumped on Monday

2018-04-10 zacks
Sanction tensions are back in Russia. The country suffered a lot in 2014 when the Obama government punished it following its Crimea (erstwhile Ukrainian territory) annexation. And now, the Trump government does not like Russia’s backing of the Syrian government (read: Russia ETFs Crash: What Went Wrong in 2014?).
WFC WFCNP WFC.WS WFC.PRL WFC.PRJ 0486 WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN KO WFC.PRY WFC.PRX WFC.PRW WFC.PRV

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

14h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

15h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...